Management of Degenerative Disc Disease
Lumbar fusion should be performed for patients whose low-back pain is refractory to conservative treatment and is due to 1- or 2-level degenerative disc disease without stenosis or spondylolisthesis. 1
Initial Conservative Management
Conservative management should be the first-line approach for degenerative disc disease (DDD), with surgical interventions reserved for refractory cases:
Non-pharmacological interventions:
Pharmacological options:
Interventional procedures:
- Epidural steroid injections - particularly effective in patients with inflammatory end-plate changes (Modic Type 1) on MRI 4
- Intradiscal steroid injections - may provide significant improvement in select patients with inflammatory end-plate changes 4
- Radiofrequency ablation - conventional or thermal radiofrequency ablation of the medial branch nerves should be performed for medial branch pain when previous diagnostic or therapeutic injections have provided temporary relief 1
Surgical Management
When conservative measures fail after an appropriate trial (typically 3 months), surgical options should be considered:
Lumbar fusion:
Discectomy:
Intradiscal Electrothermal Therapy (IDET):
- May be considered for young active patients with early single-level DDD with well-maintained disc height 1
Treatment Algorithm
First 4-8 weeks:
- Conservative management with physical therapy, NSAIDs, activity modification
- Avoid routine imaging for acute pain without red flags 2
Persistent symptoms (2-3 months):
- Consider MRI imaging to assess disc pathology and presence of inflammatory changes
- Trial of interventional procedures (epidural injections, radiofrequency ablation)
Refractory symptoms (>3 months):
- Reassess with imaging
- Consider surgical options based on specific findings:
- For 1-2 level DDD without stenosis/spondylolisthesis: lumbar fusion
- For disc herniation with radiculopathy: discectomy alone
- For recurrent herniation with instability: discectomy with fusion
Important Considerations and Pitfalls
Avoid unnecessary imaging: Routine imaging for acute low back pain (<4 weeks) without red flags provides no clinical benefit and may lead to unnecessary interventions 2
Fusion is not always necessary: Lumbar discectomy alone shows equivalent or better outcomes compared to discectomy with fusion for primary disc herniations 2
Patient selection is critical: The STarT Back tool can help identify patients at low, medium, or high risk for developing persistent disabling pain, guiding appropriate management approaches 2
Emerging therapies: Regenerative medicine approaches including mesenchymal stem cells, gene therapy, and biologic treatments show promise but lack standardized clinical data for routine use 5, 6
Prognosis: The prognosis for DDD is generally favorable with appropriate management, but patients with neurological symptoms may experience deterioration if not appropriately treated 3